Enabling Industrial Biotech Innovation in the EU: A Key Technology for Smart, Sustainable Growth
1. Technological research, consisting of taking advantage of European scientific excellence in transforming ideals from research into technologies competitive at a global level.
2. Product demonstration, in which exploitation of the KETs occurs to create innovative European product prototypes competitive at a global level.
3. Competitive manufacturing, allowing product prototypes duly validated during the demonstration phase to create and maintain in Europe attractive economic environments and globally competitive industries.
Nathalie Moll, Secretary General of EuropaBio concluded: “Without the funding mechanisms for pilot schemes and demonstrators recommended by this report being put in place the EU will continue to lose ground to emerging economies in these crucial areas. EuropaBio calls on EU decision makers across all sectors involved in the Knowledge Based Bioeconomy to make bold political moves in their support of industrial biotech and to back these up with the necessary resources.”
Most read news
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.